4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-26-035912
Chief Financial Officer sold 28,000 shares at $4.54 ($127,212)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gagnon Robert E. Chief Financial Officer | 2026-09-03 | Sale | −28,000 | $4.54 | $127,212 | 556,375 | D: show line 1 in the form |
| Open-market sales · 28,000 sh · avg $4.54 · $127,212 | |||||||
Loading xslF345X06/form4.xml…